CoreCap Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.2K Buy
159
+68
+75% +$19.4K ﹤0.01% 1299
2026
Q1
$15.8K Sell
91
-14
-13% -$2.87K ﹤0.01% 1774
2025
Q4
$26.9K Buy
105
+37
+54% +$9.7K ﹤0.01% 1568
2025
Q3
$17.7K Sell
68
-1
-1% -$263 ﹤0.01% 1719
2025
Q2
$16.9K Sell
69
-65
-49% -$16.2K ﹤0.01% 1675
2025
Q1
$35.5K Buy
134
+66
+97% +$17.9K ﹤0.01% 1311
2024
Q4
$17.3K Sell
68
-7
-9% -$1.88K ﹤0.01% 1581
2024
Q3
$23.8K Buy
+75
New +$26.7K ﹤0.01% 1478
2024
Q2
Sell
-78
Closed -$27K 2038
2024
Q1
$27K Buy
+78
New +$29.6K ﹤0.01% 1352
2022
Q4
$78.9K Buy
+154
New +$80.9K 0.01% 824
2022
Q3
Sell
-127
Closed -$59K 1206
2022
Q2
$59K Buy
+127
New +$56.5K ﹤0.01% 888
2022
Q1
Sell
-447
Closed -$207K 1216
2021
Q4
$207K Buy
+447
New +$198K 0.01% 528

Other funds holding HUM

CoreCap Advisors's HUM Position: Q2 2026 in Review

CoreCap Advisors increased its Humana (HUM) stake by 75% in Q2 2026, buying an estimated $19.4K and bringing the position to 159 shares worth $63.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

CoreCap Advisors first reported a position in HUM in Q4 2021 and has held it in 12 quarters since. The position peaked at $207K in Q4 2021. 188 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • CoreCap Advisors held 159 shares of Humana worth $63.2K as of Q2 2026.
  • CoreCap Advisors bought 68 Humana shares in Q2 2026, an estimated $19.4K.
  • Humana made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1299 holding.
  • CoreCap Advisors first reported a position in Humana in Q4 2021 and has held it in 12 quarters since.
  • CoreCap Advisors's Humana position peaked at $207K in Q4 2021.
  • 188 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.